CCA wants migraines added to Pharmacy First service
The Community Chemists' Association has called on NHS England to expand Pharmacy First by adding migraines as a clinical condition pharmacists can manage. The CCA published a report making the case, pointing to pharmacists' longstanding experience supporting patients with headaches.
What happened
The CCA released a report arguing that a significant proportion of GP headache consultations could be handled in community pharmacy instead. The association used this to back its call for migraines to be brought within the Pharmacy First service, which currently covers a set of common conditions but does not include migraine.
The CCA's argument rests on a simple premise: pharmacists already deal with headache patients regularly. That experience, the report argues, makes the case for formalising migraine management within the service rather than leaving patients to book GP appointments.
Why it matters
Pharmacy First was introduced to take pressure off general practice by routing straightforward clinical presentations through community pharmacy. The service gives pharmacists structured clinical pathways to assess and treat patients, with access to medicines that would otherwise require a GP prescription.
Migraines are one of the most common neurological conditions seen in primary care. Patients presenting with migraine often visit pharmacies first anyway — for over-the-counter painkillers, anti-emetics, or advice on whether they need to see a doctor. What the CCA is calling for is a formal pathway that reflects what's already happening on the pharmacy floor.
For the pharmacy sector, getting migraines onto the Pharmacy First list would mean a funded, recognised clinical role rather than informal support. It would also mean pharmacists could potentially initiate or manage treatments under a structured protocol, rather than referring everything beyond OTC options back to the GP.
From a workforce perspective, the argument fits a broader pattern: pharmacy bodies pushing for the profession's clinical capacity to be used more explicitly and funded accordingly.
GPhC exam relevance
Pharmacy First and the expanding clinical role of community pharmacists are areas the GPhC assessment tests. Candidates are expected to understand how medicines are accessed across different settings, what conditions sit in pharmacy-managed versus GP-managed territory, and when referral is appropriate.
Migraine also comes up in clinical reasoning questions. Knowing the difference between a primary headache disorder like migraine and red-flag presentations that need urgent referral is exactly the kind of clinical decision-making the assessment probes. If you're asked about a patient presenting with a severe or unusual headache, the question is often less about which drug and more about whether pharmacy is the right setting at all.
The CCA's report doesn't change what's currently in scope for Pharmacy First, so don't revise as if migraines are already on the list. But the underlying clinical knowledge — how migraine presents, what OTC options exist, and when to refer — is live exam territory regardless of what the service includes.
What's next
NHS England has not responded publicly to the CCA's proposal. Any formal expansion of Pharmacy First requires negotiation with NHS England and changes to the service specification, so this is the start of a lobbying process rather than an imminent policy change.
Watch for responses from NHS England and from other pharmacy bodies. If the proposal gains traction, it may appear in contract negotiation discussions ahead of the next Pharmacy First review cycle.
Source: Chemist+Druggist — https://www.chemistanddruggist.co.uk/news/clinical/include-migraines-in-pharmacy-first-service-cca-urges-MBYMERL3WRFLDANT46G5C3QRP4/